Sickle-Cell Disease Healthcare Cost in Africa: Experience of the Congo

Abstract

Background. Lack of medical coverage in Africa leads to inappropriate care that has an impact on the mortality rate. In this study, we aimed to evaluate the cost of severe acute sickle-cell related complications in Brazzaville. Methods. A retrospective study was conducted in 2014 in the Paediatric Intensive Care Unit. It concerned 94 homozygote sickle-cell children that developed severe acute sickle-cell disease related complications (average age 69 months). For each patient, we calculated the cost of care complication. Results. The household income was estimated as low (

查看原文

分享

微信好友 朋友圈 QQ好友 复制链接

本刊更多论文

非洲镰状细胞病的医疗费用:刚果的经验

背景。非洲缺乏医疗覆盖，导致护理不当，对死亡率产生影响。在这项研究中，我们旨在评估布拉柴维尔严重急性镰状细胞相关并发症的成本。方法。2014年在儿科重症监护室进行了一项回顾性研究。它涉及94名发生严重急性镰状细胞病相关并发症的纯合子镰状细胞儿童(平均年龄69个月)。对于每位患者，我们计算了护理并发症的成本。结果。27.7%的家庭收入估计较低(< 9万里亚尔/< 158.40美元)。镰状细胞相关急性并发症的住院总中位费用为65,460澳币/ 115.21美元。费用随严重急性并发症的发生因素而波动(p = 0.041)。细菌感染引起的并发症较高(从66,765 XAF / 117.50美元到135,271.50 XAF / 238.07美元)，与疟疾相关的并发症较低(从28,305/49.82 XAF到64,891.63 XAF / 114.21美元)。死亡率为17%，与病例管理费用相关(p = 0.006)。结论。在刚果，儿童镰状细胞病严重急性并发症的病例管理费用很高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。